Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -74.29x is 44% below its 4-year average of -51.75x, near the high end of its 4-year range (-17539.00x–38.39x).
98.06% above its 12-month average of -3826.77x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -17539.00x.
INTEREST COVERAGE RATIO
-74.29x
INTEREST COVERAGE RATIO AVG TTM
-3826.77x
INTEREST COVERAGE RATIO AVG 3Y
-59.21x
INTEREST COVERAGE RATIO AVG 5Y
-51.75x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+98.06%
CURRENT VS 3Y AVG
-25.48%
CURRENT VS 5Y AVG
-43.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.68x
median of 466 covered companies
CURRENT VS SECTOR MEDIAN
-1207.92%
vs the sector median at left
Cue Biopharma, Inc.
Market Cap
$173.18M
Interest Coverage Ratio
-74.29x
TTM Avg
-3826.77x
3Y Avg
-59.21x
5Y Avg
-51.75x
Market Cap
$173.23M
Interest Coverage Ratio
-48.66x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.99M
Interest Coverage Ratio
-36.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$170.85M
Interest Coverage Ratio
-38.13x
TTM Avg
21.71x
3Y Avg
21.71x
5Y Avg
21.71x
Market Cap
$175.06M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$169.85M
Interest Coverage Ratio
N/A
TTM Avg
8.41x
3Y Avg
7.29x
5Y Avg
7.29x
Market Cap
$177.66M
Interest Coverage Ratio
-2.21x
TTM Avg
15.94x
3Y Avg
15.94x
5Y Avg
15.94x
Market Cap
$165.79M
Interest Coverage Ratio
2.28x
TTM Avg
2.28x
3Y Avg
2.28x
5Y Avg
2.28x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | $173.18M | -74.29x | -3826.77x | -59.21x | -51.75x |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | -48.66x | N/A | N/A | N/A |
| Nkarta, Inc. (NKTX)vs › | $172.78M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $173.99M | -36.67x | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $170.85M | -38.13x | 21.71x | 21.71x | 21.71x |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.06M | N/A | N/A | N/A | N/A |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | N/A | 8.41x | 7.29x | 7.29x |
| Journey Medical Corporation (DERM)vs › | $177.66M | -2.21x | 15.94x | 15.94x | 15.94x |
| OptimizeRx Corp. (OPRX)vs › | $165.79M | 2.28x | 2.28x | 2.28x | 2.28x |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $182.13M | N/A | 14.48x | 14.48x | 14.48x |
Interest Coverage
-74.3x
Debt/Equity
3.81
Current Ratio
1.25
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -17539.00x |
| 2026-03-31 | -1340.75x |
| 2025-12-31 | 38.39x |
| 2025-09-30 | -100.59x |
| 2025-06-30 | -191.89x |
| 2025-03-31 | -96.09x |
| 2024-12-31 | -62.96x |
| 2024-09-30 | -46.89x |
| 2024-06-30 | -48.29x |
| 2024-03-31 | -52.56x |
| 2023-12-31 | -27.28x |
| 2023-09-30 | -39.93x |
| 2023-06-30 | -58.26x |
| 2023-03-31 | -36.16x |
| 2022-12-31 | -41.43x |
| 2022-09-30 | -88.96x |
| 2022-06-30 | -63.54x |
| 2022-03-31 | -569.52x |
| 2020-09-30 | -440.48x |
| 2020-06-30 | -437.68x |
| 2020-03-31 | -499.81x |
